PIK3CD and breast cancer: First, Carracedo et al. [60] showed that inhibition of mTORC1 with rapamycin not only activated PI3K-AKT signalling, but also induced ERK phosphorylation in BC cell lines and tumour biopsies from patients treated with the drug.